World's Best Scientists 2026 revealed!
Joseph Rubin

Joseph Rubin

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 74 19315 18133 9620 8879 208 24982

Joseph Rubin publications per year

The chart shows the history of publications by Joseph Rubin between 1976 and 2020, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Joseph Rubin published across 45 years, from 1976 to 2020, averaging 4.6 papers a year. Output peaked at 12 publications in 1978. 2 of the 208 publications appeared in the last two years.

No. of publications
5 10
Bar chart. Horizontal axis: year, 1976 to 2020. Vertical axis: number of publications, 0 to 12. Peak 12 publications in 1978. 1976: 2 publications 1977: 6 publications 1978: 12 publications 1979: 7 publications 1980: 4 publications 1981: 11 publications 1982: 9 publications 1983: 8 publications 1984: 12 publications 1985: 4 publications 1986: 7 publications 1987: 8 publications 1988: 3 publications 1989: 2 publications 1990: 4 publications 1991: 4 publications 1992: 3 publications 1993: 3 publications 1994: 2 publications 1995: 1 publication 1996: 2 publications 1997: 7 publications 1998: 7 publications 1999: 5 publications 2000: 4 publications 2001: 9 publications 2002: 7 publications 2003: 4 publications 2004: 4 publications 2005: 9 publications 2006: 5 publications 2007: 5 publications 2008: 7 publications 2009: 2 publications 2010: 3 publications 2011: 2 publications 2012: 5 publications 2013: 1 publication 2014: 3 publications 2015: 2 publications 2016: 0 publications 2017: 1 publication 2018: 0 publications 2019: 0 publications 2020: 2 publications
1976 2020

208 publications in total across all disciplines

View publications per year as a table
Joseph Rubin: publications per year, 1976 to 2020
Year Publications
1976 2
1977 6
1978 12
1979 7
1980 4
1981 11
1982 9
1983 8
1984 12
1985 4
1986 7
1987 8
1988 3
1989 2
1990 4
1991 4
1992 3
1993 3
1994 2
1995 1
1996 2
1997 7
1998 7
1999 5
2000 4
2001 9
2002 7
2003 4
2004 4
2005 9
2006 5
2007 5
2008 7
2009 2
2010 3
2011 2
2012 5
2013 1
2014 3
2015 2
2016 0
2017 1
2018 0
2019 0
2020 2
Total 208
Download as CSV

Joseph Rubin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joseph Rubin sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 201–220 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 208 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363 208
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Joseph Rubin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph Rubin sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 74–75 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 74 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574 74
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Joseph Rubin is a researcher affiliated with Mayo Clinic in the United States, specializing primarily in Medicine with a focus on endocrine and metabolic disorders as well as epidemiological studies. Their research covers clinical and translational aspects particularly related to thyroid cancer and neuroendocrine tumors.

The recent scientific contributions of Joseph Rubin include studies on the diagnosis and treatment of thyroid cancer. One notable publication is titled An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer, published in 2020 in the journal Thyroid. This study explores therapeutic options for a difficult-to-treat thyroid cancer subtype, expanding knowledge on targeted therapies.

Joseph Rubin collaborates frequently with several other researchers. Their most recurrent coauthors include:

  • Keith C. Bible
  • Michael E. Menefee
  • Chia-Chi Lin
  • Michael Millward
  • William J. Maples

The distribution of publication venues for their work appears concentrated, with the journal Thyroid hosting a notable portion of their research output.

Their main fields of study include:

  • Medicine

Within Medicine, their research has specialized subfields such as:

  • Endocrinology, Diabetes and Metabolism
  • Epidemiology

Joseph Rubin focuses on two main research topics:

  • Thyroid Cancer Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances

Best Publications

  • Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group

    C. G. Moertel;S. Frytak;R. G. Hahn;M. J. O'Connell

  • Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.

    Larry K. Kvols;Charles G. Moertel;Michael J. O'Connell;Allan J. Schutt

  • Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

    Charles G. Moertel;Larry K. Kvols;Michael J. O'Connell;Joseph Rubin

  • Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

    Thorvardur R. Halfdanarson;K. G. Rabe;J. Rubin;G. M. Petersen

  • Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

    J A Laurie;C G Moertel;T R Fleming;H S Wieand

  • Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.

    Juan M Sarmiento;Glenroy Heywood;Joseph Rubin;Duane M Ilstrup

  • High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

    Charles G. Moertel;Thomas R. Fleming;Edward T. Creagan;Joseph Rubin

  • Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

    Edward T. Creagan;Charles G. Moertel;Judith R. O'Fallon;Allan J. Schutt

  • Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.

    Matthew P. Goetz;Matthew R. Callstrom;J. William Charboneau;Michael A. Farrell

  • Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.

    Keith C Bible;Vera J Suman;Julian R Molina;Robert C Smallridge

  • A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma: Fluorouracil vs Fluorouracil and Doxorubicin vs Fluorouracil, Doxorubicin, and Mitomycin

    Stephen A. Cullinan;Charles G. Moertel;Thomas R. Fleming;Joseph R. Rubin

  • Intra-arterial Floxuridine vs Systemic Fluorouracil for Hepatic Metastases From Colorectal Cancer: A Randomized Trial

    J. Kirk Martin;Michael J. O'Connell;Harry S. Wieand;Robert J. Fitzgibbons

  • Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.

    M J O'Connell;J A Laurie;M Kahn;R J Fitzgibbons

  • Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors

    Thorvardur R Halfdanarson;Joseph Rubin;Michael B Farnell;Clive S Grant

  • Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome

    Joseph Rubin;Jaffer Ajani;William Schirmer;Alan P. Venook

  • Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.

    James N. Ingle;David L. Ahmann;Stephanie J. Green;John H. Edmonson

  • Hepatic Arterial Infusion of a Replication-selective Oncolytic Adenovirus (dl1520): Phase II Viral, Immunologic, and Clinical Endpoints

    Tony Reid;Eva Galanis;James Abbruzzese;Dan Sze

  • The management of patients with advanced carcinoid tumors and islet cell carcinomas

    Charles G. Moertel;C. Michael Johnson;Michael A. McKusick;J. Kirk Martin

  • Phase II Trial of Irinotecan in Patients With Metastatic Colorectal Carcinoma

    Henry C. Pitot;Donald B. Wender;Michael J. O'Connell;Georgene Schroeder

  • Painful Metastases Involving Bone: Feasibility of Percutaneous CT- and US-guided Radio-frequency Ablation

    Matthew R. Callstrom;J. William Charboneau;Matthew P. Goetz;Joseph Rubin

Frequent Co-Authors

Larry K. Kvols
Larry K. Kvols University of South Florida
James N. Ingle
James N. Ingle Mayo Clinic
Jeff A. Sloan
Jeff A. Sloan Mayo Clinic
Richard M. Goldberg
Richard M. Goldberg West Virginia University
Matthew P. Goetz
Matthew P. Goetz Mayo Clinic
Alex A. Adjei
Alex A. Adjei Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a future in medicine but want flexible and affordable educational options, a range of online health degrees and career pathways are available. Those interested in pharmacy can explore the cheapest online pharmacy school programs, making it more accessible to enter this vital healthcare field.

For those focused on the administrative side of healthcare, pursuing an online mhi (Master of Health Information Management) degree can open doors to in-demand careers managing health data and systems.

Careers such as medical billing and coding are also in high demand and can be started quickly through specialized certificate or degree programs. Find out how much does it cost to become a medical coder and choose affordable online options to start working in healthcare without years of schooling.

Lastly, for nurses looking to advance, there are cheap online fnp programs (Family Nurse Practitioner), offering a pathway to higher responsibility roles with flexible study options.

Best Scientists Citing Joseph Rubin

Trending Scientists

Recently Published Articles